Next Article in Journal
Autophagy in Premature Senescent Cells Is Activated via AMPK Pathway
Previous Article in Journal
Arsenic and Antimony Transporters in Eukaryotes
Open AccessArticle

A Comparative Study on the Expression, Purification and Functional Characterization of Human Adiponectin in Pichia pastoris and Escherichia coli

1
Department of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala-Lumpur, Malaysia
2
Institute of Biological Science, Faculty of Science, University of Malaya, 50603, Kuala Lumpur, Malaysia
3
Center for Research in Biotechnology for Agriculture (CEBAR), University Malaya, 50603, Kuala-Lumpur, Malaysia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2012, 13(3), 3549-3562; https://doi.org/10.3390/ijms13033549
Received: 4 January 2012 / Revised: 28 February 2012 / Accepted: 6 March 2012 / Published: 15 March 2012
Adiponectin is one of the most bioactive substances secreted by adipose tissue and is involved in the protection against metabolic syndrome, artherosclerosis and type II diabetes. Research into the use of adiponectin as a promising drug for metabolic syndromes requires production of this hormone in high quantities considering its molecular isoforms. The objective of this study is to produce recombinant human adiponectin by Pichia pastoris (P-ADP) as a cheap and convenient eukaryotic expression system for potential application in pharmaceutical therapy. For comparison, adiponectin was also expressed using the Escherichia coli (E-ADP) expression system. Adiponectin was constructed by overlap-extension PCR, and cloned in standard cloning vector and hosts. Recombinant expression vectors were cloned in the P. pastoris and E. coli host strains, respectively. SDS-PAGE and western blotting were used to detect and analyse expressed recombinant protein in both systems. Adiponectin was purified by affinity chromatography and quantified using the Bradford Assay. The results of this study indicated that P-ADP quantity (0.111 mg/mL) was higher than that of E-ADP (0.04 mg/mL) and both were produced in soluble form. However, P-ADP was able to form high molecular weights of adiponectin molecules, whilst E-ADP was not able to form isoforms higher than trimer. In addition, P-ADP was more active in lowering blood glucose compared with E-ADP. The two types of proteins were equally efficient and significantly decreased blood triglyceride and increased high density lipoprotein. We conclude that P. pastoris is able to produce high quantity of bioactive adiponectin for potential use in treatment of metabolic syndromes. View Full-Text
Keywords: adiponectin; Pichia pastoris; E.coli; recombinant protein; biological activity adiponectin; Pichia pastoris; E.coli; recombinant protein; biological activity
MDPI and ACS Style

Rothan, H.A.; Teh, S.H.; Haron, K.; Mohamed, Z. A Comparative Study on the Expression, Purification and Functional Characterization of Human Adiponectin in Pichia pastoris and Escherichia coli . Int. J. Mol. Sci. 2012, 13, 3549-3562.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop